Paulson, James C. Litigation, Intellectual Property, Attorneys, SEC Filings, and Other Public Records

Federal Dockets	12
Active	1989–2002
Patent Assignments	31

On PlainSite Chat

No one has posted about Paulson, James C. yet.

Share something about Paulson, James C.:

Add a document

Date Recorded	Party	Role	Document Type	Document No.	Invention Title

1/9/2025	The Scripps Research Institute	Assignee	Application	63402335	Hybrid Nanoparticles For Inducing Immune Tolerance

4/5/2024	The Scripps Research Institute	Assignee	Application Application Application Publication	PCT/US2021/0 63054516 18041715 20230293711	Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance To Cell Activat...

4/5/2024	The Scripps Research Institute	Assignee	Application Application Application Publication	63054516 PCT/US2021/0 18041715 20230293711	Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance To Cell Activat... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati...

4/5/2024	The Scripps Research Institute	Assignee	Application Application Application Publication	18041715 63054516 PCT/US2021/0 20230293711	Disruption Of Cd28-sialoside Ligand Complexes To Enhance To Cell Activat... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati...

4/5/2024	The Scripps Research Institute	Assignee	Application Application Application Publication	63054516 PCT/US2021/0 18041715 20230293711	Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance To Cell Activat... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati...

4/5/2024	The Scripps Research Institute	Assignee	Application Application Application Publication	63054516 PCT/US2021/0 18041715 20230293711	Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance To Cell Activat... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati...

4/5/2024	The Scripps Research Institute	Assignee	Application Application Application Publication	18041715 63054516 PCT/US2021/0 20230293711	Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance To Cell Activat... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati...

4/5/2024	The Scripps Research Institute	Assignee	Application Application Application Publication	18041715 63054516 PCT/US2021/0 20230293711	Disruption Of Cd28-sialoside Ligand Complexes To Enhance To Cell Activat... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati... Disruption Of Cd28-sialoside Ligand Complexes To Enhance T Cell Activati...

3/21/2024	The Scripps Research Institute	Assignee	Application Application Publication Publication	18036844 18036844 20240238422 20240238422	Hypoimmunogenic Biotherapeutics Hypoimmunogenic Biotherapeutics

3/21/2024	The Scripps Research Institute	Assignee	Application Application Publication	PCT/US2022/0 18036844 20240238422	Hypoimmunogenic Biotherapeutics Hypoimmunogenic Biotherapeutics Hypoimmunogenic Biotherapeutics

3/21/2024	The Scripps Research Institute	Assignee	Application Application Publication	18036844 PCT/US2022/0 20240238422	Hypoimmunogenic Biotherapeutics Hypoimmunogenic Biotherapeutics Hypoimmunogenic Biotherapeutics

3/21/2024	The Scripps Research Institute	Assignee	Application Application Publication	18036844 PCT/US2022/0 20240238422	Hypoimmunogenic Biotherapeutics Hypoimmunogenic Biotherapeutics Hypoimmunogenic Biotherapeutics

3/10/2023	Osprey Biopharmaceuticals, Inc.	Assignee	Application	63388887	Autoantigens Engineered To Suppress Autoimmune Response

5/4/2022	The Scripps Research Institute	Assignee	Application Publication	17755382 20230037822	Immune Cell Receptor Antibodies Conjugated To High Affinity Siglec-ligan... Immune Cell Receptor Antibodies Conjugated To High Affinity Siglec-ligan...

5/4/2022	The Scripps Research Institute	Assignee	Application Publication	17755382 20230037822	Immune Cell Receptor Antibodies Conjugated To High Affinity Siglec-ligan... Immune Cell Receptor Antibodies Conjugated To High Affinity Siglec-ligan...

12/23/2020	The Scripps Research Institute	Assignee	Application	PCT/US2020/0	Immune Cell Receptor Antibodies Conjugated To High Affinity Siglec-ligan...

5/29/2019	The Scripps Research Institute	Assignee	Application Publication	16315796 20190151444	Desensitizing Mast Cells By Co-presentation Of Antigens With High Affini... Desensitizing Mast Cells By Co-presentation Of Antigens With High Affini...

5/29/2019	The Scripps Research Institute	Assignee	Application Publication Patent	16315796 20190151444 10994006	Desensitizing Mast Cells By Co-presentation Of Antigens With High Affini... Desensitizing Mast Cells By Co-presentation Of Antigens With High Affini... Desensitizing Mast Cells By Co-presentation Of Antigens With High Affini...

2/1/2016	The Scripps Research Institute	Assignee	Application Publication	14786419 20160060324	Methods and Compositions for Treating Bleeding Disorders Methods and Compositions for Treating Bleeding Disorders

3/12/2013	Scripps Research Institute	Assignee	Application Publication Patent	13261580 20130171233 9522183	Compositions And Methods For Inducing Immune Tolerance Compositions And Methods For Inducing Immune Tolerance Compositions And Methods For Inducing Immune Tolerance

3/4/2013	Scripps Research Institute	Assignee	Application Publication Application	13261581 20130164364 9326939	Liposome Targeting Compounds And Related Uses Liposome Targeting Compounds And Related Uses

2/21/2012	Scripps Research Institute	Assignee	Application Patent	13261580 9522183	Uniquely identifying a network-connected entity Compositions And Methods For Inducing Immune Tolerance

7/14/2011	The Regents Of The University Of Califor...	Assignee	Application Application Patent Patent	08446875 08102385 5962294 5858751	Compositions And Methods For Producing Sialyltransferases Compositions And Methods For The Identification And Synthesis Of Sialylt... Compositions And Methods For The Identification And Synthesis Of Sialylt... Compositions And Methods For Producing Sialyltransferases

7/14/2011	Cytel Corporation	Assignee	Application Application Patent Patent	08102385 08446875 5962294 5858751	Compositions And Methods For Producing Sialyltransferases Compositions And Methods For Producing Sialyltransferases Compositions And Methods For The Identification And Synthesis Of Sialylt... Compositions And Methods For The Identification And Synthesis Of Sialylt...

4/27/2011	National Institutes Of Health (nih), U.s...	Assignee	Application Publication Patent	12084723 20090238837 8357671	High Affinity Siglec Ligands High Affinity Siglec Ligands High Affinity Siglec Ligands

4/21/2011	National Institutes Of Health (nih), U.s...	Assignee	Application Publication Patent	12084723 20090238837 8357671	High Affinity Siglec Ligands High Affinity Siglec Ligands High Affinity Siglec Ligands

3/18/1999	Cytel Corporation	Assignee	Application Patent	09087117 6376475	Controlof Immune Responses By Modulating Activity Of Glycosyltransferase... Controlof Immune Responses By Modulating Activity Of Glycosyltransferase...

8/10/1998	Cytel Corporation	Assignee	Application Patent	09007741 6399336	Practical In Vitro Sialylation Of Recombinant Glycoproteins Practical In Vitro Sialylation Of Recombinant Glycoproteins

9/6/1994	Cytel Corporation	Assignee	Application Patent	08202047 5800815	Antibodies To P-selectin And Their Uses Antibodies To P-selectin And Their Uses

12/13/1993	Cytel, Inc.	Assignee	Application Patent	08057528 5409817	Use Of Trans-sialidase And Sialyltransferase For Synthesis Of Sialylalph... Use Of Trans-sialidase And Sialyltransferase For Synthesis Of Sialylalph...

12/8/1989	Regents Of The University Of California	Assignee	Application Patent	07426577 5032519	Method For Producing Secretable Glycosyltransferases And Other Golgi Pro... Method For Producing Secretable Glycosyltransferases And Other Golgi Pro...

12/2/1982	Regents Of The University Of California	Assignee	Application Patent	06446231 4557931	Antigenic Compositions And Methods For Using Same Antigenic Compositions And Methods For Using Same

32 Rows Total

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.

AI text generation	None
AI document summarization	None
AI-augmented search	None
AI-generated images	None
AI chat or Q&A interface	Linkable via MCP
Third party AI contribution in government documents	Possible